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The regulation of neostriatal cholinergic function by tachy- 
kinins (TKs) has been studied by measuring endogenous 
ACh released from rat neostriatal slices. Septide (SEP; a 
highly selective substance P analog), neurokinin A (NKA), 
and neurokinin B (NKB) elicited endogenous ACh release in 
a concentration-dependent manner. The rank order in po- 
tency was the following: NKB (EC,, = 0.5 nM) > NKA (EC, 
= 7 nu) > SEP (EC,, = 12 nM). Spantide (SPA) was less 
effective (39% inhibition) than [D-Args, D-Trp7.9, KMethyl- 
Phea]-substance P fragment 6-11 (53% inhibition) at antag- 
onizing ACh release evoked by SEP and NKA. Smaller doses 
of the antagonists inhibited the effects of SEP compared to 
NKA, and the effects of NKB could only be antagonized by 
SPA. These findings suggest the involvement of the three 
neurokinin (NK) receptors in ACh release evoked by TKs 
with the following rank order: NK, > NK, > NK,. 
6-Hydroxydopamine lesions of nigrostriatal neurons and 
tetrodotoxin (TTX) intoxication of striatal tissue revealed two 
different patterns of regulation of cholinergic function by 
TKs. On the one hand, SEP and NKA evoked ACh release, 
independently of the nigrostriatal dopaminergic system, by 
acting on NK, and NK, receptors that are probably localized 
on the somatodendritic field of cholinergic neurons receiving 
substance P terminals. On the other hand, dopaminergic ter- 
minals seem to regulate NKB neurons that modulate cholin- 
ergic neurons, because NKB-evoked ACh release decreased 
by 24% in the denervated striata. In addition, TTX partially 
blocked (50%) ACh release evoked by NKB, suggesting that 
NKB acts on NK, receptors at both the nerve terminals and 
the somatodendritic field of cholinergic neurons. Therefore, 
NKB neurons could play a crucial role in regulating cholin- 
ergic terminals by partially mediating the dopaminergic in- 
fluence on cholinergic neurons. This finding may provide 
some clues in the organization of the basal ganglia and in 
the understanding of basal ganglia disorders. 
The neostriatum is known to contain some of the highest amounts 
of cholinergic markers in the CNS (K&a, 1986). Cholinergic 
neurons in the rat neostriatum have been identified by ChAT 
immunocytochemistry as large or giant aspiny interneurons (Bo- 
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lam et al., 1984; Wainer et al., 1984; Phelps et al., 1985). Al- 
though cholinergic neurons represent a small population in the 
neostriatum (McGeer et al., 1984; Graybiel et al., 1986) their 
widespread dendritic and axonal fields, high sensitivity to small 
depolarizing potentials, and tonic firing place them in an ex- 
cellent position to act as modulators ofthe excitability of neostri- 
atal projection neurons in advance of the onset of movement- 
related neostriatal activity (Wilson et al., 1990). Thus, all these 
properties endow cholinergic neurons with a key role in basal 
ganglia functions and disorders, resulting in a very sensitive 
marker of neostriatal function. 
Tachykinins (TKs) constitute a neuropeptide family widely 
distributed and active in both the CNS and peripheral tissues. 
The endogenous mammalian members of this family are sub- 
stance P (SP), neurokinin A (NKA), and neurokinin B (NKl:; 
Maggio, 1988). Although the immunohistochemical localization 
ofthese peptides has been difficult because ofthe cross-reactivity 
between antibodies to different TKs, two distinct populations 
of medium-sized neurons containing SP immunoreactivity have 
been described in the neostriatum (Bolam et al., 1983; Bolam 
and Izzo, 1988; Gerfen and Young, 1988). Furthermore, SP- 
containing terminals have been reported to synapse on the so- 
matodendritic tree of cholinergic neurons (Bolam et al., 1986) 
and on medium-sized neurons (Bolam et al., 1983; Bolam and 
Izzo, 1988). Recently, in situ hybridization studies have per- 
mitted the differentiation between SP and NKB transcripts 
(Warden and Young, 1988). In the neostriatum, cells expressing 
NKB have been found to be present either scattered or in small 
clusters projecting to the globus pallidus (Burgunder and Young, 
1989). Furthermore, these cells coexpress neurotransmitters 
present in two medium-sized neurons: SP is found in 59% and 
enkephalin in 25% of the NKB-positive cells (Burgunder and 
Young, 1989). At the moment, specific probes for the histo- 
chemical localization of NKA are not available. However, lesion 
studies have suggested that SP and NKA could be coexisting in 
some of the striatonigral-projecting neurons (J. M. Lee et al., 
1986; Lindefors et al., 1986) which also give extensive striatal 
innervation (DiFiglia et al., 1980; Wilson and Groves, 1980; 
Somogyi et al., 1981). Molecular biology studies have shown 
that both SP and NKA are generated from @- and y-preprotachy- 
kinin A mRNAs (Krause et al., 1987) suggesting that the source 
of SP/NKA terminals in the neostriatum is common in some 
neurons. 
The endogenous TKs (SP, NKA, and NKB) act as preferred, 
but not exclusive, endogenous ligands of the three classes of 
neurokinin (NK) receptor subtypes, NK,, NK,, and NK,, re- 
spectively (Quirion and Dam, 1988; Watson and Abbot, 1990). 
The activation of NK receptors induces excitatory effects in 
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several neural systems and releases many neuroactive sub- 
stances (Maggio, 1988; Kangrga and Randic, 1990; Reid et al., 
1990). Both in vitro (Lindefors et al., 1985) and in vivo (Lindefors 
et al., 1989) experiments have shown that TKs are released in 
a Ca*+ -dependent fashion in the neostriatum. Furthermore, au- 
toradiographic studies have revealed moderate levels of the three 
classes of NK receptors in this nucleus (Saffroy et al., 1988; Dam 
et al., 1990). These data, together with the subcellular localiza- 
tion of TKs in synaptosomes and vesicle fractions (Diez-Guerra 
et al., 1987), are consistent with the role of TKs as neurotrans- 
mitters in the neostriatum. According to this role, SP has been 
reported to increase the firing rate of some striatal neurons (Le 
Gal La Salle and Ben-Ari, 1977) and to evoke the release of )H- 
dopamine (Starr, 1978, 1982; Petit and Glowinski, 1986; Baruch 
et al., 1988), endogenous dopamine (Reid et al., 1990), ‘H-5 
HT (Starr, 1978), and 3H-Met-enkephalin (Del Rio et al., 1983) 
in the neostriatum. Although NKA and NKE3 have also been 
reported to evoke the release of )H-dopamine (Petit and Glo 
winski, 1986; Glowinski et al., 1988), much less is known about 
the neurotransmitter role of NKA or NKB in the neostriatum, 
and evidence in favor of the regulation of striatal interneurons 
or intrastriatal circuits has not been obtained. 
The present study was designed to investigate the regulation 
of neostriatal cholinergic neurons by TKs. Endogenous ACh 
release from neostriatal slices was continuously measured by 
means of a chemiluminescent method. The aims of this study 
were (1) to determine the role of activation and blockade of the 
three NK receptors on the regulation ofendogenous ACh release, 
(2) to establish NK dependence on the dopaminergic system by 
means of 6-hydroxydopamine (6-OHDA) denervation, and (3) 
to depict the possible localization of the receptor(s) involved in 
such regulation by using the fast sodium channel blocker tetro- 
dotoxin (TTX). The results indicate a differential pattern of 
tachykininergic regulation of ACh release. Our data provide first 
evidence of a novel excitatory regulation of neostriatal cholin- 
ergic interneurons by SP, NKA, and NKB. 
Materials and Methods 
Materials. ACh chloride, choline oxidase (EC 1.1.3.17), HRP type VI 
(EC 1.11.1.7), luminol (5-amino-2,3-dihydro- 1,4-phthalazinedione), 
AChE type VI-S (EC 3.1.1.7), 6-hydroxydopamine hydrochloride, sep- 
tide (SEP, [p-Glu6, Pro9]-substance P fragment 6-l l), neurokinin A (also 
known as substance K, cu-neurokinin, neuromedin L), neurokinin B (also 
known as P-neurokinin or neuromedin K), spantide (SPA; [o-A@, 
D-TID'.~. Leu”l-substance P). and [D-A&. D-T&~, N-methyl-Phes]- 
.  I  , ,  
substance P fragment 6- 11 (SPAF) were iuichaseh from Sigma. Tetr& 
dotoxin was supplied by Boehringer Mannheim. 
6-Hydroxydopumine l sions. Male Spragu+Dawley rats (15&250 gm) 
were anesthetized with ketamine (150 mg/kg, i.p.) and placed in a David 
Kopf sterotaxic apparatus (DK 900). The incisor bar was placed 5 mm 
above the interaural line. A microinjection cannula was implanted into 
the medial forebrain bundle at the following coordinates: 1.6 mm caudal 
to bregma, 1.3 mm lateral to the midline, and 8.4 mm under the brain 
surface, according to the atlas of Pellegrino et al. (1979). Unilateral 
6-OHDA (8 &2 11) was injected at a rate of 1 rl/min, using a Harvard 
Apparatus syringe infusion pump 22. Rats were tested 1 month after 
surgery for contralateral circling behavior with apomorphine (0.5 mgl 
kg, s.c.) as described previously (Arenas et al., 199 1). Only the animals 
that rotated contralateral to the lesion at a rate of at least 5 rpm during 
1 hr were used in this study. 
Tissue sampling. Lesioned and unlesioned rats were killed by decap- 
itation. Brains were removed, and neostriata were quickly dissected out. 
Slices of about 4 mg wet weight and 500 pm thick were prepared. The 
slices were placed in a standard saline solution (NaCl, 136 mM; KCl, 
5.6 mM; MgCl,, 1.2 mM; Tris/HCl, 10 mM, pH 7.4; and glucose, 5 mM) 
at room temperature and equilibrated with a mixture of 0, (95%) and 
CO, (5%) for 1 hr as previously described (Alberch et al., 1985, 1990; 
Arenas et al., 1990a). 
Endogenous ACh assay. ACh release was measured by the chemilu- 
minescent method described by Isra&l and Lesbats (1982) with some 
modifications (Arenas et al., 1990b). This method is based on the lu- 
minol-peroxidase chemiluminescent reaction, which uses the H,O, gen- 
erated by the oxidation of choline to betaine. In this assay, the slices 
were placed in a tube containing the luminescent mixture: NaCl, 136 
mM; KCl, 5.6 mM; MgCl,, 1.2 mM; CaCl,, 5 mM; Tris/HCl, 10 mM, pH 
7.7; choline oxidase, 2.5 W/ml; HRP, 0.01 mg/ml; luminol, 5 PM; and 
AChE, 5 IU/ml. The tube was placed in front of the photomultiplier, 
and ACh release was evoked by adding KC1 (50 mM) or TKs at different 
concentrations ranging from 10 PM to 10 PM. The peak of released ACh, 
recorded for each sample, was compared with the peak obtained by the 
injection ofan ACh standard dose of 100 pmol in the same tube. Finally, 
the slices were weighed, and the results were expressed in nmol of ACh 
per gram of wet tissue per minute. 
Incubations. Incubations with TTX were performed by immersing 
the slices for 12 min in a tube containing the standard saline solution 
plus 0.3 PM TTX. After this period, the slices were placed in another 
tube containing the luminescent mixture and subsequently depolarized 
with TKs or KC1 (50 mM). Incubations with the antagonists were per- 
formed directly in the tube containing the chemiluminescent mixture. 
Spantide and [D-Arg’, D-T~F, N-methyl-Phes]-substance P fragment 
6- 11 were injected 1 min before depolarization with the corresponding 
agonist. 
All the drugs injected into the luminescent mixture were tested for 
their ability to modify the light emission. None of the peptides used in 
the experiments quenched or enhanced the chemiluminescent reaction 
itself. 
Results 
Effects of TK agonists on ACh release 
The three TK agonists SEP, NKA, and NKB elicited ACh release 
from rat neostriatal slices in a concentration-dependent manner 
(Fig. 1). The relative efficacy of the TKs to evoke ACh release 
with respect to ACh release elicited by KC1 (50 mM) was the 
following: NKA, 70-78%; NKB, 70-73%; and SEP, 60-63% 
(KC1 control values, 9.01 ? 0.28 nmol ACh/gm wet tissueimin). 
Maximal release of ACh was obtained at the following concen- 
trations: 10.01 PM NKB, 20.1 PM NKA, and 2 1 I.~M SEP. In 
the absence of Ca2+, ACh release evoked by TKs was abolished 
(data not shown). 
The relative potencies of the TKs on endogenous ACh release 
were determined from the concentration-response curves (Fig. 
1). The rank order of the relative potency of the three agonists 
was the following: NKB > NKA > SEP, with an EC,, of ap- 
proximately 0.5 nM for NKB, 7 nM for NKA, and 12 nM for 
SEP. 
Effects of TK antagonists on ACh release evoked by TKs 
To determine whether TK-evoked ACh release was specific, we 
used the TK antagonists SPA and SPAF. SPA at a concentration 
of 10 PM antagonized 35-39% of the excitatory effects of 1 PM 
SEP, 0.1 PM NKA, and 0.0 1 PM NKB (Fig. 2). The excitatory 
effects of 1 FM SEP and 0.1 WM NKA were inhibited by 52% 
with a concentration of SPAF of 10 FM (Fig. 3). However, at 
this same concentration of SPAF, the effects of NKB were not 
inhibited. Thus, ACh release elicited by the three TK agonists 
shows a differential sensitivity to blockade by SPA and SPAF. 
Effect of TTX on striatal ACh release evoked by TKs 
In order to study the dependence on fast Na+ channels of the 
excitatory effects of TKs on ACh release, neostriatal tissue was 
incubated with TTX (0.3 PM) before KC1 (50 mM) or TK de- 
polarization. As we previously described (Arenas et al., 1990a), 
TTX significantly reduced, by about 30%, ACh release evoked 
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Figure 1. Dose-response curves of the excitatory effects of TKs on 
endogenous ACh release from rat neostriatal slices. NKB (circles), NKA 
(diamonds), or SEP (triangles) were directly injected at different con- 
centrations into the detection medium containing the slice. Endogenous 
ACh release was immediately triggered and registered on line. Each 
point corresponds to the mean value & SEM of three or more different 
experiments performed with duplicate or triplicate determinations. 
by KC1 (Fig. 4). TTX blocked by 70% the ACh release elicited 
by SEP (1 FM) or NKA (0.1 PM), similar to that described for 
glutamate (Arenas et al., 1990a). In contrast, TTX partially 
inhibited (by 50%) ACh release evoked by 0.01 FM NKB (Fig. 
4). 
Eflects of unilateral injection of 6-OHDA in the nigrostriatal 
pathway on ACh release evoked by TKs 
ACh release elicited by KC1 or TKs from the nonlesioned neo- 
striatum was not significantly different from ACh release in 
nonlesioned animals. Similarly, ACh release evoked by KC1 (50 
mM), SEP (1 FM), or NKA (0.1 /IM) in the ipsilateral side to the 
6-OHDA lesion was not different from that of the nonlesioned 
side. However, ACh release evoked by NKB (0.01 PM) in the 
ipsilateral side was reduced 24% with respect to the contralateral 
side (Fig. 5) suggesting a desensitization of the cholinergic re- 
sponse to NKB. 
Discussion 
Efects of TKs on striatal ACh release 
In the present study, endogenous ACh release was elicited from 
rat neostriatal slices by SEP, a potent and selective NK, agonist 
(C.-M. Lee et al., 1986; Wormser et al., 1986; Laufer et al., 
1988) and by NKA and NKB, the endogenous agonists of NK, 
and NK, receptors, respectively (Quirion and Dam, 1988; Wat- 
son and Abbot, 1990). It is interesting to note that our dose- 
response studies showed sigmoidal curves for the three agonists, 
suggesting the involvement of single saturable receptors for each 
response. This could be due either to the activation of NK, 
receptors by higher doses of NKA and SEP, or to the activation 
of NK, and NK, receptors by NKA and SEP, respectively. This 
latter possibility is in agreement with other studies (Baruch et 
al., 1988) which showed that the two endogenous agonists, 
NKA and NKB, had no cross-activity and clear differential 
effects on nigrostriatal dopaminergic neurons at very similar 
concentrations to those used in the present study. Furthermore, 
the application of NKA in the substantia nigra pars compacta 
has also been reported to be more effective than SP at exciting 
nigral dopaminergic neurons (Innis et al., 1985) and to require 
a lo-fold lower concentration than SP to increase the release of 
3H-dopamine in the caudate nucleus (Baruch et al., 1988). In 
addition, NKA has also been reported to be 10 times more 
potent than SP at increasing the locomotor activity in rats when 
infused into the ventral tegmental area (Kalivas et al., 1985). 
However, the most potent TK at evoking ACh release in the 
neostriatum was NKB, which, in contrast, has been reported to 
have no effect on 3H-dopamine release in the caudate nucieus 
when applied in the substantia nigra pars compacta (Baruch et 
al., 1988). These data are in good agreement with the very low 
concentrations of NKB in the substantia nigra. Therefore, the 
presence of small populations of both NKB and cholinergic 
neurons in the neostriatum suggests that the potent effect of 
NKB on cholinergic neurons reflects a very close link between 
both NKB and cholinergic neurons. 
Characterization of receptors mediating physiological effects 
has been largely based on the use of specific high-affinity an- 
tagonists, but for the TKs no such antagonists have been found. 
TK antagonists currently available are not fully specific and 
sometimes antagonize the actions of all TKs (Maggio, 1988). 
However, because NK receptor subtypes exhibit a differential 
sensitivity to blockage by various antagonists, these antagonists 
can provide information on the receptors involved. In order to 
determine the participation of different receptor subtypes, we 
used SPA, a relatively nonselective TK antagonist (C.-M. Lee 
et al., 1986; Iverfeldt et al., 1990) and SPAF, a relatively se- 
lective antagonist for the NK, receptor (Laufer et al., 1985). 
Because SPA antagonized the excitatory effects of SEP, NKA, 
and NKB on ACh release, it provided confirmation that ACh 
release evoked by TKs is due to the activation of NK receptors. 
Furthermore, the potency of SPA at antagonizing the effects of 
TKs on ACh release coincides with the affinity pattern of SPA 
for NK receptors (NK, > NK, > NK,) in binding experiments 
(C.-M. Lee et al., 1986; Buck and Shatzer, 1988). Similarly, our 
results with SPAF are consistent with the pattern of receptors 
antagonized by SPAF: NK, 2 NK, (Laufer et al., 1985; Buck 
and Shatzer, 1988), with no effect on NK, receptors (Laufer et 
al., 1985). Thus, SPAF shares with SPA the relatively high 
affinity for NK, receptors and the IO-fold greater selectivity for 
NK, receptors with respect to NK, receptors, but differs from 
SPA in its inactivity on NK, receptors and its higher effectivity 
(52% inhibition by SPAF vs. 38% by SPA). 
The present data, according to the characteristics of NK re- 
ceptors (C.-M. Lee et al., 1986; Watson and Abbot, 1990) are 
consistent with a major involvement of NK, receptors in the 
excitatory influence of TKs on endogenous ACh release from 
rat neostriatal slices. Furthermore, our results with the antag- 
onists suggest that the rank order in potency of the three agonists 
at evoking endogenous ACh release (NKB > NKA > SEP) could 
correspond to the activation of the three NK receptors coupled 
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3ffects of SPA on endogenous ACh release evoked by TKs. 
No antagonist (open bars) or different concentrations of SPA ([D-Arg’, 
~-Trp’.~, Lcu”]-substance P), 0.1 PM (hatched bar), 1 PM (cross-hatched 
bars), or 10 PM (solid bars), were injected into the detection medium 
containing the slice, 1 min before depolarization with 1 WM SEP, 0.1 
PM NM, or 0.0 1 PM NKB. SPA required 1 O-fold higher concentrations 
than SEP, 100-fold higher concentrations than NKA, and lOOO-fold 
higher concentrations than NKB (10 PM) to antagonize partially their 
effects on ACh release, suggesting the following rank order in potency: 
SEP > NIL4 > NKB. Each value corresponds to the mean + SEM of 
four or more different experiments performed with duplicate or triplicate 
determinations. The statistical significance was evaluated by the Stu- 
dent’s t test for nonpaired data with Bonferroni’s correction for four 
comparisons. **, P < 0.0025 compared with the corresponding open 
bar. 
to ACh release with the following rank order: NK, > NK, > 
NK,. 
TTX sensitivity of TK effects on cholinergic neurons 
TTX has been often used to detect the participation of axonal 
transmission, which depends on fast Na+ channels (Raitieri et 
al., 1984). However, in the case of neosttiatal cholinergic in- 
temeurons, TTX cannot distinguish between activity mediated 
by polysynaptic paths and activity mediated by the dendrites 
and axons of the cholinergic neurons, because the entire cell is 
present in the preparation (Arenas et al., 1990a). In the present 
study, TTX blocked the excitatory effects of both SEP and NKA 
on endogenous ACh release from neostriatal slices, indicating 
that nerve conduction was involved in mediating the response. 
This is in agreement with the coexistence of NKALSP and with 
the well-known SP input to the cell bodies and proximal den- 
drites of cholinergic intemeurons (Bolam et al., 1986). Thus, 
the blockade of ACh release evoked by SEP and NKA is prob- 
ably due to the TTX blockade of axonal transmission following 
somatodendritic activation of cholinergic neurons, as has been 
previously reported for ACh release evoked by glutamate (Scat- 
ton and Lehmann, 1982; Arenas et al., 1990a). Furthermore, 
lesion studies using kainate and 6-OHDA showed that SP bind- 
ing sites in the neostriatum were mainly located on striatal cell 
bodies and dendrites rather than on afferent nerve terminals 
(Ritter et al., 1985; Mantyh and Hunt, 1986). These results have 
been confirmed by the TTX sensitivity of 3H-dopamine release 
evoked by SP in striatal slices, which involves polysynaptic 
paths and suggests the absence of SP receptors on dopaminergic 
terminals (Petit and Glowinski, 1986). 
SEP NKA NKB 
Figure 3. Effects of SPAF on endogenous ACh release evoked by TKs. 
No antagonist (open bars) or different concentrations of SPAF ([o-Arg6, 
~-Trp’.~, N-Methyl-Phe8]-substance P fragment G 11, 1 PM (cross-hatched 
bars) or 10 FM (solid bars), were injected into the detection medium 
containing the slice, 1 min before depolarization with 1 FM SEP, 0.1 
PM NKA, or 0.01 PM NKB. Note that SPAF was more potent at antag- 
onizing ACh release evoked by SEP than by NKA, and that it did not 
antagonize the effects of NKB. Each value corresponds to the mean f  
SEM of four or more different experiments performed with duplicate 
or triplicate determinations. The statistical significance was evaluated 
by the Student’s t test for nonpaired data with Bonferroni’s correction 
for four comparisons. **, P < 0.0025 compared with the corresponding 
open bar. 
The case of NKB is rather different, because TTX partially 
inhibited (50%) ACh release elicited by NKB. This observation 
suggests that NKB could partially act at both the somatoden- 
dritic field and nerve terminals of cholinergic neurons. It is very 
unlikely that the NKB effect at the somatodendritic field could 
be mediated by those NK receptors activated by SP or NKA, 
because SPAF antagonized the effects of SP and NKA but not 
those of NKB on NK, receptors. Alternatively, two populations 
of NKB-containing neurons acting on NK, receptors could be 
postulated. The first one, providing somatodendritic input to 
the cholinergic neurons, could be responsible for the TTX-sen- 
sitive effects on ACh release, and the second NKB population 
could provide input to the nerve terminals of cholinergic neu- 
rons, resulting in a TTX-resistant effect on ACh release. 
Because SP terminals are in synaptic contact with the so- 
matodendritic field of cholinergic neurons (Bolam et al., 1986) 
and SP evoked ACh release in a TTX-sensitive manner, it is 
very likely that the 59% of NKB mRNA-containing neurons 
that coexist with SP (Burgunder and Young, 1989) could cor- 
respond to the population of NKB neurons that provides TTX- 
sensitive input to the somatodendritic field of cholinergic neu- 
rons. In contrast, the 25% of NKB mRNA-containing neurons 
that coexist with enkephalin (Burgunder and Young, 1989) could 
correspond to the population of NKB neurons providing TTX- 
resistant input to the choline@ terminals. This possibility is 
further supported by the TTX-resistant effects of &opioids on 
ACh release in the neostriatum (Arenas et al., 1990a) mediated 
by dopaminergic terminals (Arenas et al., 199 1). 
The dopaminergic modulation of the tachykininergic control of 
cholinergic neurons 
Neurons containing SP have been reported to be the major target 
of nigrostriatal dopaminergic neurons in the head of the caudate 
nucleus (Beckstead, 1987). Furthermore, dopaminergic input to 
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Figure 4. Effects of TTX on endogenous ACh release evoked by 50 
mM KCI, 1 PM SEP, 0.1 PM N&i, or 0.0 1 PM NKB from rat neostriatal 
slices. Open bars, control ACh release; hatched bars, TTX (0.3 PM) 
diminished by 32% ACh release evoked by KCI, blocked by 70% ACh 
release evoked by SEP and NKA, and partially prevented (50%) ACh 
release evoked by NKB. Each value corresponds to the mean + SEM 
of four different experiments performed with duplicate or triplicate 
determinations. The statistical significance was evaluated by the Stu- 
dent’s t test for paired data. ** P < 0.01 compared with the corre- , 
sponding open bar. 
striatal neurons has been shown to modulate the biosynthesis 
and levels of many neurotransmitters or neuromodulators. Uni- 
lateral 6-OHDA lesions of the dopaminergic nigrostriatal path- 
way have shown two patterns of regulation. The first pattern is 
consistent with a downregulation, leading to a decrease in striatal 
SP levels (Voom et al., 1987), SP mRNA (Young et al., 1986; 
Sivam et al., 1987) and dynorphin levels (Jiang et al., 1990). 
This downregulation was followed neither by the release of SP 
and NKA in the neostriatum (Lindefors et al., 1989) nor by 
altering the effects of SP and NKA on ACh release in the 
6-OHDA-lesioned striatum (present results). Instead, the do- 
paminergic denervation decreased SP and NKA release in the 
substantia nigra (Lindefors et al., 1989). Thus, it is likely that 
the downregulation of SP levels (Voom et al., 1987) and mRNA 
(Young et al., 1986; Sivam et al., 1987) in the neostriatum 
reflected the dopaminergic regulation of SP/NKA striatonigral 
neurons together with a masked or absent dopaminergic regu- 
lation of SP/NKA interneurons. 
The second pattern of regulation of striatal neuronal activity 
is consistent with an upregulation of other neuronal systems, 
which leads to an increase in GABA levels (Lindefors et al., 
1989) glutamic acid decarboxylase levels (Vernier et al., 1988) 
enkephalin mRNA (Young et al., 1986; Sivam et al., 1987; 
Vernier et al., 1988), enkephalin levels (Voom et al., 1987; Jiang 
et al., 1990) and NKB mRNA (Burgunder and Young, 1989). 
These changes have also been reported to be followed by an 
increase in the release of some of these neurotransmitters such 
as GABA (Lindefors et al., 1989). Evidence in favor of the 
dopaminergic regulation of NKB release is still lacking; how- 
ever, because both GABA and NKB exhibited an upregulation, 
it is reasonable to assume an increased release of NKB. Then, 
an increase in endogenous NKB release could lead to a desen- 
sitization of NK, receptors coupled to ACh release. This event 
is very likely responsible for the decreased response of cholin- 
ergic neurons to exogenously applied NKB after 6-OHDA le- 
KC1 SEP NKA NKB 
Figure 5. Effects of dopaminergic nigrostriatal deafferentation on en- 
dogenous ACh release evoked bv 50 mM KCI. 1 UM SEP. 0.1 UM NKA. 
or >.Ol PM NKB from rat neostriatal slices. .Oden bars; A& release 
evoked from the contralateral side to the 6-OHDA injection; cross- 
hatched bars, ACh release evoked from the ipsilateral side to the 
6-OHDA injection, where only the effect of NKB was significantly re- 
duced. Each value corresponds to the mean + SEM of five different 
experiments performed with duplicate or triplicate determinations. The 
statistical significance was evaluated by the Student’s t test for paired 
data. *, P < 0.05 compared with the corresponding open bar. 
sions. Furthermore, desensitization of TK receptors by high 
concentrations of TK agonists has been reported (Laufer et al., 
1988). 
These findings suggest hat the tonic dopaminergic influence 
on cholinergic neurons (Lehmann and Langer, 1983; Alberch et 
al., 1985) could be partially mediated by nerve terminals of 
NKB neurons acting on cholinergic terminals. This possibility 
is supported by the hyperactivity of NKB mRNA-containing 
neurons after the dopaminergic denervation (Burgunder and 
Young, 1989), by the dopaminergic regulation of NKB-evoked 
ACh release (present results), and by the partially TTX-resistant 
effect of NKB on ACh release (present results). Furthermore, 
the dopaminergic hyperactivity of the remaining terminals after 
the dopaminergic denervation (Zigmond et al., 1990) may be 
the result of the hyperactivity of NKB mRNA-containing neu- 
rons (Burgunder and Young, 1989). 
Our results provide evidence favoring the idea that part of 
the dopaminergic regulation of cholinergic function can be me- 
diated by NKB. This hypothesis suggests that the population of 
NKB neurons acting on cholinergic terminals could play an 
important role in the dopaminergic regulation of cholinergic 
neurons and in the regulation of neostriatal function. However, 
this hypothesis requires further testing, because NKB could also 
affect other neurotransmitter systems. 
Implications for the basal ganglia disorders 
Huntington’s disease is characterized by the loss of small- and 
medium-sized spiny neurons containing GABA, enkephalin, and 
TKs (Kowal et al., 1987). In these patients, SP and NKA levels 
in caudate-putamen, globus pallidus, and substantia nigra are 
decreased, though NKB levels in the caudate-putamen and the 
external segment of the globus pallidus are unchanged (Arai et 
al., 1987). Interestingly, this spared pattern of NKB levels is 
coincident with the pattern described for striatal neurons ex- 
pressing NKB mRNA (Burgunder and Young, 1989), which 
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possibly regulate neostriatal cholinergic neurons. These obser- 
vations reinforce the idea of a differential regulation of SP/ 
NKA- and NKB-containing neurons. Furthermore, these find- 
ings are in agreement with our hypothesis of a possible partial 
mediation by NKEl terminals of the dopaminergic input to cho- 
line@ neurons. The predominance of the dopaminergic neu- 
rotransmission in the neostriatum (Spokes, 198 1) may lead to 
a tonic inhibition of NKB release from NKB-containing neurons 
and to a decrease in ACh release. If  so, the enhancement of the 
NKB spared neurotransmission may help to restore the balance 
between ACh and dopamine. 
In Parkinson’s disease, there is a decrease in the striatal levels 
of dopamine (Hornykiewicz, 1982), an increase in the striatal 
levels of GABA (Perry et al., 1983), and a decrease in the con- 
tents of SP in the substantia nigra and external globus pallidus, 
but not in the caudate-putamen or the internal globus pallidus 
(Agid and Javoy-Agid, 1985). Unfortunately, no data are avail- 
able concerning modifications of NKEI levels in Parkinson’s 
disease; however, two opposite patterns of dopaminergic reg- 
ulation of striatal neurons can be observed as described for 
6-OHDA lesions. Therefore, in agreement with the mediation 
of the dopaminergic input to cholinergic neurons by NKB, a 
possible increase in the release of NKB in Parkinson’s disease 
and 6-OHDA lesions may be responsible for the predominance 
of the cholinergic neurotransmission in the neostriatum. If this 
is true, NKB antagonists or NKB-depleting therapy, acting on 
a spared population of neurons and at the next step of the 
dopaminergic input, may have a role in the control ofcholinergic 
function and in the recovery of motor symptoms in Parkinson’s 
disease. 
Further work and highly selective NKB antagonists are re- 
quired to determine fully the role of the NKB system in the 
dopaminergic input to cholinergic neurons and in basal ganglia 
disorders. 
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